Insiders who reported open-market trades in the last 12 months at the companies Janet Dillione files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Steven W. Lefkowitz - $475K in CRMD purchases and sales in the last 12 months
Joseph Todisco - $360K in CRMD purchases and sales in the last 12 months
Myron Kaplan - $276K in CRMD purchases and sales in the last 12 months
Alan W. Dunton - $260K in CRMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Janet Dillione is a corporate insider, tracked as Director of CorMedix Inc. (CRMD). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Janet Dillione submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Janet Dillione been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.55M) across all tracked filings.
Janet Dillione is Director of CorMedix Inc. (CRMD). 7 SEC Form 4 filings on record going back to 2025, most recently on 19 September 2026. Most recent open-market trade: sold $69K of CRMD on 23 January 2026. Lifetime open-market sales: $1.55M.
Recent transactions
16
The latest 16 SEC Form 4 transactions reported by Janet Dillione.
InsiderAlpha's records for Janet Dillione go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. 13 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
